Molecular Pathology in Solid Tumors
A special issue of Journal of Molecular Pathology (ISSN 2673-5261).
Deadline for manuscript submissions: closed (15 October 2021) | Viewed by 59888
Interests: predictive molecular pathology in solid tumors; next generation technologies in molecular biology; liquid biopsies; predictive oncology
Special Issues, Collections and Topics in MDPI journals
This is the era of molecular pathology. Today, any aspect of modern medicine is indissolubly related to the pleiotropic world of molecular pathology. In this very exciting scenario, one of the main aims of this new discipline is to find the right way for the right patients, starting from an integrated morpho-molecular diagnosis, through the correct biomarker evaluation for treatment patient selection. In this setting, the implementation of next-generation technologies in association with the differential management of biological samples (e.g., tissue and body fluids) has become the key weapon to improve the clinical outcome of cancer patients.
Moreover, the application of molecular tests to the cytological diagnosis of several neoplasms such as that of the thyroid gland could improve the risk stratification of patients, allowing either a surgical or medical tailored treatment.
In this Special Issue, entitled “Molecular Pathology in Solid Tumors”, we would like to discuss new insights into Molecular Pathology, useful to improve the diagnosis and treatment of solid tumors, with a focus on predictive molecular tests in lung tumors and diagnostic molecular tests in thyroid nodules. Potential topics include but are not limited to the following:
1) Biomarker discovery;
2) Precision oncology;
3) Morpho-molecular diagnosis in solid tumors;
4) Molecular tests applied to the diagnosis of thyroid neoplasms;
5) Predictive molecular pathology for target treatment patient selections;
6) Application of next-generation technologies in diagnostic and predictive molecular pathology.
The following article types will be considered: Article, Review, Opinion, Perspective.
Dr. Umberto Malapelle
Prof. Dr. Claudio Bellevicine
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular pathology
- solid tumors
- next-generation technologies, target treatment